Global Whole Slide Imaging Market - Segmented by Technology and by End User - Growth, Trends, and Forecast (2022 - 2030)
The whole slide imaging market is expected to witness a CAGR of 17.00% during the forecast period. North America is the dominant for the whole slide imaging due to several factors, such as rising adoption of digital pathology and increase in awareness regarding growing advantages of whole slide imaging over the traditional histopathological slides imaging.
Technological Advancements in Whole Slide Imaging
Major advances in digital technology have occurred since the introduction of handheld electronic devices, including the development of whole slide imaging (WSI) systems with software packages that can convert microscope images into virtual (digital) slides that can be viewed on the computer monitors and through the internet. However, these technological developments have had minimal impact on the way pathologists perform their daily work, with the exception of using computers to access electronic medical records and scholarly websites for pertinent information to assist interpretation of cases. This is expected to drive the adoption rate of whole slide imaging systems for the diagnostic purposes.
Additionally, increasing incidence of cancer and public & private initiative for the digital pathology is driving the global whole slide imaging market.
High Cost of Whole Slide Imaging Systems
FDA has approved the whole slide imaging systems for primary diagnosis, which is expected to improve the market, however, the reluctance towards digital pathology due to the high cost of the whole slide imaging systems is acting as a restraint to the market. It is estimated that a whole slide imaging system installation approximately costs USD 130,000, which is inhibiting the pathologists from adopting whole slide imaging systems.
Additionally, pending regulatory approvals are also restraining the growth of global whole slide imaging market.
North America is dominating the market
North America, owing to factors such as rising adoption of digital pathology and increase in awareness regarding growing advantages of whole slide imaging over the traditional histopathological slides imaging, is dominating the whole slide imaging market. Furthermore, the growing need of whole slide analysis due to a rise in disease prevalence in the region and growing trend of adoption of digital platform in healthcare sectors would further boost the market growth in North America. For instances, about 1.5 billion histopathological slides are investigated manually each year in the U.S. alone, which is likely to augment a huge demand for whole slide imaging among the end users in the region.
Key Developments in the Market
• January 2018: Inspirata acquired Toronto based Artificial Intelligence in Medicine, Inc. (AIM) to enhance its R&D in artificial intelligence.
• January 2018: Inspirata acquired digital pathology company Omnyx from GE Healthcare for primary diagnosis in Europe and Canada
Major Players: OLYMPUS CORPORATION, PHILIPS HEALTHCARE, DEFINIENS AG, LEICA MICROSYSTEMS GMBH, VENTANA MEDICAL SYSTEMS INC., NIKON CORPORATION, VISIOPHARM, 3DHISTECH, HAMAMATSU PHOTONICS K.K., INDICA LABS, INSPIRATA AND MIKROSCAN TECHNOLOGIES INC., amongst others.
Reasons to Purchase this Report
• Current and future whole slide imaging market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• Identifying the segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Technological Advancements in Whole Slide Imaging
Major advances in digital technology have occurred since the introduction of handheld electronic devices, including the development of whole slide imaging (WSI) systems with software packages that can convert microscope images into virtual (digital) slides that can be viewed on the computer monitors and through the internet. However, these technological developments have had minimal impact on the way pathologists perform their daily work, with the exception of using computers to access electronic medical records and scholarly websites for pertinent information to assist interpretation of cases. This is expected to drive the adoption rate of whole slide imaging systems for the diagnostic purposes.
Additionally, increasing incidence of cancer and public & private initiative for the digital pathology is driving the global whole slide imaging market.
High Cost of Whole Slide Imaging Systems
FDA has approved the whole slide imaging systems for primary diagnosis, which is expected to improve the market, however, the reluctance towards digital pathology due to the high cost of the whole slide imaging systems is acting as a restraint to the market. It is estimated that a whole slide imaging system installation approximately costs USD 130,000, which is inhibiting the pathologists from adopting whole slide imaging systems.
Additionally, pending regulatory approvals are also restraining the growth of global whole slide imaging market.
North America is dominating the market
North America, owing to factors such as rising adoption of digital pathology and increase in awareness regarding growing advantages of whole slide imaging over the traditional histopathological slides imaging, is dominating the whole slide imaging market. Furthermore, the growing need of whole slide analysis due to a rise in disease prevalence in the region and growing trend of adoption of digital platform in healthcare sectors would further boost the market growth in North America. For instances, about 1.5 billion histopathological slides are investigated manually each year in the U.S. alone, which is likely to augment a huge demand for whole slide imaging among the end users in the region.
Key Developments in the Market
• January 2018: Inspirata acquired Toronto based Artificial Intelligence in Medicine, Inc. (AIM) to enhance its R&D in artificial intelligence.
• January 2018: Inspirata acquired digital pathology company Omnyx from GE Healthcare for primary diagnosis in Europe and Canada
Major Players: OLYMPUS CORPORATION, PHILIPS HEALTHCARE, DEFINIENS AG, LEICA MICROSYSTEMS GMBH, VENTANA MEDICAL SYSTEMS INC., NIKON CORPORATION, VISIOPHARM, 3DHISTECH, HAMAMATSU PHOTONICS K.K., INDICA LABS, INSPIRATA AND MIKROSCAN TECHNOLOGIES INC., amongst others.
Reasons to Purchase this Report
• Current and future whole slide imaging market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• Identifying the segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
